Hematology/Oncology

Top Story

Nivolumab, ipilimumab combination shows promise for renal cell carcinoma

Nivolumab, ipilimumab combination shows promise for renal cell carcinoma
July 21, 2017

Combination therapy with nivolumab and ipilimumab led to notable antitumor activity and durable response among patients with metastatic renal cell carcinoma, according to safety and efficacy results of the CheckMate 016 clinical trial.

“For this group of patients, these are very significant results,” Hans J. Hammers, MD, PhD, associate professor of internal medicine at UT Southwestern, and co-leader of the kidney cancer program at The Harold C. Simmons Compressive Cancer Center, said in a press release.

CDC: Multicomponent interventions boost colorectal, breast, cervical cancer screening

July 21, 2017
Multicomponent interventions effectively increase colorectal cancer screening with colonoscopy or fecal occult blood testing, according to a CDC report. The CDC’s…
In the Journals Plus

Race, ethnicity impact use of autologous stem cell transplantation for multiple myeloma

July 21, 2017
Hispanic patients with multiple myeloma in the United States demonstrated the lowest usage rate for autologous hematopoietic stem cell transplantation, according to a…
Meeting News

Combination demonstrates activity in extensive stage small cell lung cancer

July 21, 2017
CHICAGO — The combination of veliparib and cisplatin/etoposide conferred benefit to patients with extensive stage small cell lung cancer, according to results from…
In the Journals Plus

Variables play role in medullary thyroid carcinoma survival rates

July 21, 2017
Adults with medullary thyroid carcinoma with a large tumor size, high calcitonin level and cervical metastases have a decreased 5-year survival compared with those with…
More News Headlines »
CME

Immune Checkpoint Inhibitors for Advanced Bladder Cancer: Applying Clinical Advances and Elucidating Best Practices

This activity is supported by an educational grant from Merck & Co, Inc.

Advances in immunology and the advent of immune checkpoint blockade inhibition for advanced bladder cancer are poised…
More »
Video
Meeting News

VIDEO: Results of LATITUDE trial reinforce long-hypothesized theory in prostate cancer treatment

June 21, 2017
More »
Resource Centers
Biosimilars in the US

Biosimilars in the US

CME

The Patient with Invasive Breast Cancer

No commercial support for this activity.

This CME activity will focus on the diagnosis and management of patients with invasive breast cancer.
More »
Current Issues
View the Current Issue
HemOnc Today
Advertisement
Advertisement